Advertisement
Advertisement
BSX
Boston Scientific Corp.
53.93
USDSponsored
-2.64
-4.67%
May 08, 16:00 UTC -4
Closed
After-Market
54.05
+0.12
+0.22%
BSX Earnings Reports
Positive Surprise Ratio
BSX beat 33 of 41 last estimates.
80%
Next Report
Date of Next Report
Jul 21, 2026
Estimate for Q2 26 (Revenue/ EPS)
$5.45B
/$0.84
Implied change from Q1 26 (Revenue/ EPS)
+4.84%
/+5.00%
Implied change from Q2 25 (Revenue/ EPS)
+7.78%
/+12.00%
Boston Scientific Corp. earnings per share and revenue
On Apr 22, 2026, BSX reported earnings of 0.80 USD per share (EPS) for Q1 26, beating the estimate of 0.79 USD, resulting in a 0.69% surprise. Revenue reached 5.20 billion, compared to an expected 5.22 billion, with a -0.35% difference. The market reacted with a +8.99% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 22 analysts forecast an EPS of 0.84 USD, with revenue projected to reach 5.45 billion USD, implying an increase of 5.00% EPS, and increase of 4.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were Boston Scientific Corp.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Boston Scientific Corp. reported EPS of $0.80, beating estimates by 0.69%, and revenue of $5.20B, -0.35% below expectations.
How did the market react to Boston Scientific Corp.'s Q1 2026 earnings?
The stock price moved up 8.99%, changed from $59.52 before the earnings release to $64.87 the day after.
When is Boston Scientific Corp. expected to report next?
The next earning report is scheduled for Jul 21, 2026.
What are the forecasts for Boston Scientific Corp.'s next earnings report?
Based on 22
analysts, Boston Scientific Corp. is expected to report EPS of $0.84 and revenue of $5.45B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement